These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 31654330)
1. Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults. Yoshida R; Yoshizako T; Katsube T; Kitagaki H Jpn J Radiol; 2019 Dec; 37(12):826-831. PubMed ID: 31654330 [TBL] [Abstract][Full Text] [Related]
2. [A case of ceftriaxone-associated pseudolithiasis in an adult patient that disappeared after the discontinuation of ceftriaxone]. Tomoda T; Ueki T; Saito S; Tatsukawa M; Nawa T; Hamamoto H; Endo H; Yabushita K; Shimoe T; Sakaguchi K Nihon Shokakibyo Gakkai Zasshi; 2013 Aug; 110(8):1481-6. PubMed ID: 23912008 [TBL] [Abstract][Full Text] [Related]
3. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis. Murata S; Aomatsu T; Yoden A; Tamai H Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455 [TBL] [Abstract][Full Text] [Related]
5. Sudden-onset gallbladder rupture due to Ceftriaxone-associated pseudolithiasis in a patient with acquired hemophilia A. Harada N; Shibano I; Mukai D; Kizawa Y; Shiragami H; Takayanagi S; Hosaka N; Mugitani A; Hino M J Infect Chemother; 2023 Aug; 29(8):796-799. PubMed ID: 37075980 [TBL] [Abstract][Full Text] [Related]
6. Ceftriaxone-associated Pseudolithiasis in Elderly People: Frequency and Risk Factors. Hotta K; Hashimura N; Takatsuka M; Matsuyama T; Nakagawa K; Yabusako T; Hosomi S; Fujiwara Y Intern Med; 2021; 60(24):3857-3864. PubMed ID: 34911872 [TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone-associated Pseudolithiasis in the Gallbladder and Bile Duct of an Elderly Patient. Yamabe A; Irisawa A; Wakabayashi H; Tsunoda T; Tominaga K Intern Med; 2020 Nov; 59(21):2725-2728. PubMed ID: 32669492 [TBL] [Abstract][Full Text] [Related]
8. [Clinical review and case report of ceftriaxone-associated gallbladder pseudolithiasis in adult]. Jung HK; Lee DS Korean J Gastroenterol; 2014 Jun; 63(6):378-81. PubMed ID: 24953617 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of Endoscopic Managements in Patients with Ceftriaxone-Induced Pseudolithiasis Causing Biliary Obstruction. Doi Y; Takii Y; Ito H; Jingu N; To K; Kimura S; Kimura K; Sanefuji K; Ikeda H; Tachibana S; Otsuka T Case Rep Med; 2017; 2017():3835825. PubMed ID: 29230246 [TBL] [Abstract][Full Text] [Related]
10. Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction. Imafuku A; Sawa N; Sekine A; Kawada M; Hiramatsu R; Yamanouchi M; Hasegawa E; Hayami N; Hoshino J; Ubara Y; Takaichi K Clin Exp Nephrol; 2018 Jun; 22(3):613-619. PubMed ID: 29027036 [TBL] [Abstract][Full Text] [Related]
11. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections. Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458 [TBL] [Abstract][Full Text] [Related]
12. Reversible Ceftriaxone-Induced Pseudolithiasis in an Adult Patient with Maintenance Hemodialysis. Shima A; Suehiro T; Takii M; Soeda H; Hirakawa M Case Rep Nephrol Dial; 2015; 5(3):187-91. PubMed ID: 26558252 [TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone-associated Biliary Pseudolithiasis with Elderly Type 1 Diabetes Mellitus: Two Case Reports. Kanazawa K; Suzuki S; Inaba T; Koga S; Kuwabara K Intern Med; 2023 Nov; 62(22):3367-3371. PubMed ID: 37032086 [TBL] [Abstract][Full Text] [Related]
14. Hemodialysis as a Risk Factor for Ceftriaxone-Associated Pseudolithiasis in Adults. Ubukata M; Ohsawa I; Suzuki H; Asao R; Nakamura Y; Nishida H; Nakamura M; Nitta K; Goto Y; Gotoh H Ther Apher Dial; 2020 Aug; 24(4):393-399. PubMed ID: 31626369 [TBL] [Abstract][Full Text] [Related]
15. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study. Acun C; Erdem LO; Söğüt A; Erdem CZ; Tomaç N; Gündoğdu S; Cavuldak S Ann Trop Paediatr; 2004 Mar; 24(1):25-31. PubMed ID: 15005963 [TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract infection. Krzemień G; Książczyk T; Szmigielska A; Bombiński P; Roszkowska-Blaim M; Werner B; Brzewski M Dev Period Med; 2015; 19(2):182-5. PubMed ID: 26384120 [TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone-associated biliary sludge and pseudocholelithiasis during childhood: a prospective study. Bor O; Dinleyici EC; Kebapci M; Aydogdu SD Pediatr Int; 2004 Jun; 46(3):322-4. PubMed ID: 15151550 [TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone-induced pseudolithiasis in children treated for perforated appendicitis. Alemayehu H; Desai AA; Thomas P; Sharp SW; St Peter SD Pediatr Surg Int; 2014 Mar; 30(3):323-6. PubMed ID: 24464035 [TBL] [Abstract][Full Text] [Related]
19. Ceftriaxone-associated biliary pseudolithiasis in children: do we know enough? Cuzzolin L; Oggiano AM; Clemente MG; Locci C; Antonucci L; Antonucci R Fundam Clin Pharmacol; 2021 Feb; 35(1):40-52. PubMed ID: 32492204 [TBL] [Abstract][Full Text] [Related]